Elevated expression of CTHRC1 predicts unfavorable prognosis in patients with pancreatic ductal adenocarcinoma.

MLA

Liu, Wei, et al. “Elevated Expression of CTHRC1 Predicts Unfavorable Prognosis in Patients with Pancreatic Ductal Adenocarcinoma.” American Journal of Cancer Research, vol. 6, no. 8, Aug. 2016, pp. 1820–27. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=27648368&authtype=sso&custid=ns315887.

APA

Liu, W., Fu, X.-L., Yang, J.-Y., Yang, M.-W., Tao, L.-Y., Liu, D.-J., Huo, Y.-M., Zhang, J.-F., Hua, R., & Sun, Y.-W. (2016). Elevated expression of CTHRC1 predicts unfavorable prognosis in patients with pancreatic ductal adenocarcinoma. American Journal of Cancer Research, 6(8), 1820–1827.

Chicago

Liu, Wei, Xue-Liang Fu, Jian-Yu Yang, Min-Wei Yang, Ling-Ye Tao, De-Jun Liu, Yan-Miao Huo, Jun-Feng Zhang, Rong Hua, and Yong-Wei Sun. 2016. “Elevated Expression of CTHRC1 Predicts Unfavorable Prognosis in Patients with Pancreatic Ductal Adenocarcinoma.” American Journal of Cancer Research 6 (8): 1820–27. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=27648368&authtype=sso&custid=ns315887.